How did Merck's Pharmaceutical segment perform in Q4 2024?

Merck's Pharmaceutical segment performed well in Q4 2024, with strong revenue and profitability metrics. The segment reported total revenue of $15.62 billion, operating income of $4.17 billion, and net income of $3.75 billion for the quarter.

|code|Ticker|Name|Date|Operating Income|Total Revenue|Net Income|market_code|
|---|---|---|---|---|---|---|---|
|MRK|MRK.N|Merck|2024 Q1|5.67E9|1.5775E10|4.767E9|169|
|MRK|MRK.N|Merck|2024 Q2|6.006E9|1.6112E10|5.461E9|169|
|MRK|MRK.N|Merck|2024 Q3|4.09E9|1.6657E10|3.161E9|169|
|MRK|MRK.N|Merck|2024 Q4|4.17E9|1.5624E10|3.745E9|169|